Former New England Patriots player Martellus Bennett's Super Bowl ring from the team's historic 28-3 comeback win over the Atlanta Falcons netted $88,125 at auction.
The New England Patriots released offensive tackle Chukwuma Okorafor ahead of his looming NFL free agency in March.
A New England Patriots reporter gave his thoughts about the GOAT debate between Tom Brady and Patrick Mahomes.
Arguably the most talked about storyline surrounding the New England Patriots heading into the NFL offseason has been the need for a wide receiver. Drake Maye showed off legitimate superstar ...
The New England Patriots are entering the offseason with a whole lot of issues they need to address, but the good news is they have the cap room to fix them. The Patriots have more money available ...
FOXBORO -- New England Patriots Super Bowl hero Adam Vinatieri will have to wait at least another year to become a Hall of Famer. Vinatieri was not among the Pro Football Hall of Fame Class of ...
The New England Patriots finished their 2024 season with a 4-13 record and outside of the playoffs again which put them in position to fire their head coach for the second year in a row.
As the New England Patriots prepare for the 2025 NFL season, they have many issues they'll need to address, and their offensive line is among the most pressing. At this point, it would be smart ...
The New England Patriots finished the 2024 season with a 4-13 record for the second season in a row, leading to their second ...
Both players have either been linked to the Patriots in the past or New England has been viewed as a possible fit. An AFC executive told ESPN’s Jeremy Fowler that the Patriots would be ...
Little went right for the Patriots in 2024. While shortcomings on the offensive line and a dearth of proven playmakers across the roster were to be expected, New England’s steady defense ...
From Friends University to the USFL to the NFL, defensive lineman Jeremiah Pharms Jr.‘s unlikely story will continue in New England. As noted by his agency, the Patriots have re-signed Pharms to a two ...